In the United States, During the time period between 1999 and 2020, more than 263,000 people died from overdoses involving prescription opioids. As many as one in four people receiving prescription opioids in a primary care setting struggles with addiction. Between January 2019 and June 2020, more than 90% of benzodiazepine-involved overdose deaths also involved […]
In the United States, During the time period between 1999 and 2020, more than 263,000 people died from overdoses involving prescription opioids. As many as one in four people receiving […]
Join us to learn about promising practices from Berkshire Health, Vermont CARES and the NH Harm Reduction program. We welcome you to share about your efforts too! Upon attending […]
Join Healthcentric Advisors’ Dr. Rebekah Gardner and Marghie Guiliano as well as Jenn McCarthy, LPC, New England Rural Health Association, to explore validated assessment tools, consider the new CDC prescribing guidelines, discuss complementary therapies, and explore tools and resources that will help your team support your patients and community. Upon attending this session, participants will […]
Join us as Seth Clark, MD & Juliette Holtzman, MSW from LifeSpan Addiction Medicine team share their approach to supporting individuals living with Opioid Use Disorder. Upon attending this session, […]
IPRO and the Opioid Response Network (ORN) have developed an education series for use by nursing home staff educators. Our goal is to provide a resource to nursing homes/medical rehabilitation centers that supports your commitment to ensure all residents/patients receive equitable care. This education series will address the often missed, yet impactful issues of addiction, […]
WHAT IS AN AFFINITY GROUP? Affinity Groups highlight best practices, resources, and successful solutions to challenges. Opioid Stewardship Affinity Group attendees will: Discuss how to initiate/expand a hospital Opioid Stewardship […]
More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than one in five received medication to treat this condition. In addition, the number of patients who stay in treatment after hospital discharge decrease drastically. This webinar series is a collaboration between all Quality Innovation Network-Quality Improvement […]
More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than one in five received medication to treat this condition. In addition, the number of patients who stay in treatment after hospital discharge decrease drastically. This webinar series is a collaboration between all Quality Innovation Network-Quality Improvement […]
Learning Objectives At the completion of this activity learners will be able to: Describe how to effectively recognize and respond to an opioid-involved breathing emergency, including considerations with xylazine and illicitly manufactured fentanyl. Counsel patients and caregivers on how to use unregulated substances more safely and where to find recovery resources. Dispel myths and provide […]
More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than one in five received medication to treat this condition. In addition, the number of patients who stay in treatment after hospital discharge decrease drastically. This webinar series is a collaboration between all Quality Innovation Network-Quality Improvement […]
More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020. However, fewer than one in five received medication to treat this condition. In addition, […]